N., D. T.; C., R. B.; N., K. K. Mortality and survival benefits in people living with human immunodeficiency virus initiated newly with Antiretroviral therapy irrespective of CD4 count. International Journal of Advances in Medicine, [S. l.], v. 7, n. 2, p. 272–275, 2020. DOI: 10.18203/2349-3933.ijam20200078. Disponível em: https://www.ijmedicine.com/index.php/ijam/article/view/2087. Acesso em: 17 nov. 2025.